Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial Fibrillation
- 17 January 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 125 (2), 216-225
- https://doi.org/10.1161/circulationaha.111.053272
Abstract
Background—: Several lines of evidence have suggested that maintenance of atrial fibrillation (AF) depends on reentrant mechanisms. Maintenance of reentry necessitates a sufficiently short refractory period and/or delayed conduction, and AF has been associated with both alterations. Fibrosis, cellular dysfunction, and gap junction protein alterations occur in AF and cause conduction delay. We performed this study to test the hypothesis that gap junction protein overexpression would improve conduction and prevent AF. Methods and Results—: Thirty Yorkshire swine were randomized into 2 groups (sinus rhythm and AF), and each group into 3 subgroups: sham-operated control, gene therapy with adenovirus expressing connexin (Cx) 40, and gene therapy with adenovirus expressing Cx43 (n=5 per subgroup). All animals had epicardial gene painting; the AF group had burst atrial pacing. All animals underwent terminal study 7 days after gene transfer. Sinus rhythm animals had strong transgene expression but no atrial conduction changes. In AF animals, controls had reduced and lateralized Cx43 expression, and Cx43 gene transfer restored expression and cellular location to sinus rhythm control levels. In the AF group, both Cx40 and Cx43 gene transfer improved conduction and reduced AF relative to controls. Conclusions—: Connexin gene therapy preserved atrial conduction and prevented AF.Keywords
This publication has 43 references indexed in Scilit:
- Inhibitory G Protein Overexpression Provides Physiologically Relevant Heart Rate Control in Persistent Atrial FibrillationCirculation, 2004
- Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failureCardiovascular Research, 2004
- Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythmThe American Journal of Cardiology, 2003
- Cx40 and Cx43 expression ratio influences heteromeric/ heterotypic gap junction channel propertiesAmerican Journal of Physiology-Cell Physiology, 2002
- Structural correlate of atrial fibrillation in human patientsCardiovascular Research, 2002
- Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?Cardiovascular Research, 2002
- Heterotypic gap junction channel formation between heteromeric and homomeric Cx40 and Cx43 connexonsAmerican Journal of Physiology-Cell Physiology, 2001
- Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular FunctionCirculation, 2001
- Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial FibrillationCirculation, 2001
- Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goatCardiovascular Research, 2000